Scotland · NHS Scotland MSAN
Diazepam 10mg/2ml solution for injection ampoules
MSAN(2025)21 · Level 2 · issued 07 May 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| stock holdings, especially in cases where surplus unused stock is available. | Available | — |
| lorazepam, and rectal diazepam, remain available and can support a full increase in demand. | Available | — |
| 9. The following alterative benzodiazepines remain available and can support a full uplift in supply: | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2025:21
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
ba9fcf98665ef9a8a40fc00b3dfe10f1b3f97c40ce0bfce554f0a0a2563c3af5sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2025-21.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.